Tüm alıştırma soruları

8270 soru

Soru 2281Soru →

A 45-year-old man is hospitalized for the treatment of acute promyelocytic leukemia. Eight days ago, he was started on induction therapy with all-trans retinoic acid and arsenic trioxide, along with empiric intravenous cefepime for neutropenic fever. Over the last 2424 hours, his temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, pulse is 112/min112/\text{min}, and respirations are 24/min24/\text{min}. Oxygen saturation is 89%89\% on room air. He reports progressive shortness of breath and a nonproductive cough. Physical examination reveals bilateral basilar crackles, 2+2+ bilateral lower extremity edema, and elevated jugular venous pressure. Laboratory studies show a leukocyte count of 28,000/mm328,000/\text{mm}^3 (up from 4,000/mm34,000/\text{mm}^3 on admission). Chest radiography demonstrates bilateral diffuse interstitial opacities and small bilateral pleural effusions. Which of the following is the most specific and critical next step in the management of this patient's acute respiratory decompensation?

Cevabı ve açıklamayı göster

Cevap: Intravenous dexamethasone

Cevap

Intravenous dexamethasone
The correct answer is the immediate administration of intravenous dexamethasone. This patient is presenting with Differentiation Syndrome (formerly known as retinoic acid syndrome), a life-threatening complication of induction therapy with all-trans retinoic acid (ATRA) and arsenic trioxide for acute promyelocytic leukemia (APL). As the malignant promyelocytes are forced to differentiate into mature neutrophils, they release massive amounts of inflammatory cytokines. This results in a systemic inflammatory response syndrome characterized by fever, peripheral edema, weight gain, hypotension, and profound capillary leak leading to pulmonary infiltrates, pleural effusions, and pericardial effusions. The diagnostic hallmark often includes a rapidly rising leukocyte count. The definitive, life-saving therapy is the immediate initiation of high-dose corticosteroids, specifically intravenous dexamethasone, which rapidly blunts the cytokine storm. Importantly, ATRA is typically continued during moderate differentiation syndrome; temporary discontinuation is reserved only for severe cases (e.g., acute respiratory distress syndrome requiring intubation or acute renal failure).

Adım Adım Çözüm

1
Identify the primary diagnosis and current treatment.
The patient has acute promyelocytic leukemia (APL) and is receiving induction therapy with all-trans retinoic acid (ATRA) and arsenic trioxide.
Establishing the current therapeutic context is essential for identifying treatment-specific complications.
2
Analyze the new clinical presentation and timeline.
Eight days after starting ATRA, the patient developed fever, dyspnea, hypoxemia, weight gain (edema), a rising leukocyte count, and bilateral pulmonary opacities.
This timeline and symptom cluster (fever, pulmonary infiltrates, effusions, expected leukocytosis) are the hallmark signs of a specific adverse drug reaction.
3
Formulate a diagnosis for the acute decompensation.
The clinical picture perfectly matches Differentiation Syndrome (formerly retinoic acid syndrome), caused by differentiating promyelocytes releasing inflammatory cytokines.
Recognizing the capillary leak nature of this syndrome prevents misdiagnosing it as isolated heart failure or pneumonia.
4
Select the definitive management for the complication.
The treatment of choice is immediate high-dose intravenous dexamethasone.
Steroids are required to suppress the life-threatening cytokine storm. ATRA is generally continued unless the syndrome is severe (e.g., renal failure, need for intubation).

Anahtar Kavram

Differentiation Syndrome in APL
Soru 2282Soru →

Match each patient's clinical presentation and laboratory profile with the most likely corresponding peripheral blood smear finding.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 24-year-old man develops acute jaundice and dark urine 2 days after initiating trimethoprim-sulfamethoxazole. Vitals: T 37.2°C, HR 105, BP 120/78. Exam shows scleral icterus. Labs: Hemoglobin 8.5 g/dL, Total bilirubin 4.2 mg/dL, Direct bilirubin 0.6 mg/dL.
A 45-year-old home renovator presents with colicky abdominal pain and wrist drop. Vitals: T 37.0°C, HR 88, BP 145/90. Exam shows right hand extensor weakness. Labs: Hemoglobin 9.2 g/dL, MCV 78 fL, Creatinine 1.4 mg/dL.
A 29-year-old woman with a history of recurrent vaso-occlusive crises presents for a checkup. Vitals: T 36.8°C, HR 82, BP 115/75. Exam shows no palpable spleen. Labs: Hemoglobin 7.8 g/dL, Reticulocytes 8.5%, WBC 12,000/mm³.
A 34-year-old woman with systemic lupus erythematosus presents with rapidly worsening fatigue. Vitals: T 37.5°C, HR 112, BP 110/70. Exam shows pale conjunctivae and jaundice. Labs: Hemoglobin 7.1 g/dL, Reticulocytes 11%, LDH 650 U/L, positive direct antiglobulin test.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The sulfonamide-induced hemolysis matches Heinz bodies and bite cells; the home renovator with wrist drop matches basophilic stippling; the sickle cell patient matches Howell-Jolly bodies; and the lupus patient with a positive direct antiglobulin test matches spherocytes.
Each vignette represents a classic hematologic presentation where the peripheral blood smear serves as a critical diagnostic tool, reflecting the exact underlying mechanism of erythrocyte damage, abnormal maturation, or failed splenic clearance.

Adım Adım Çözüm

1
Analyze each clinical vignette to establish the primary pathophysiologic diagnosis.
Diagnoses identified: 1 is G6PD deficiency, 2 is lead poisoning, 3 is sickle cell disease with autosplenectomy, and 4 is warm autoimmune hemolytic anemia.
Correctly identifying the underlying disease process is a prerequisite to anticipating its microscopic cellular features.
2
Correlate the identified diagnoses with classic peripheral blood smear morphological changes.
G6PD deficiency links to Heinz bodies/bite cells. Lead poisoning links to basophilic stippling. Autosplenectomy links to Howell-Jolly bodies. Warm AIHA links to spherocytes.
Specific pathophysiological mechanisms directly dictate the morphological alterations of erythrocytes visible on a peripheral smear.

Anahtar Kavram

Correlating clinical presentations of hematologic disorders with their characteristic pathophysiological peripheral blood smear findings.
Soru 2283Soru →

A 52-year-old woman with a history of primary Sjögren syndrome, characterized by severe keratoconjunctivitis sicca, xerostomia, and positive anti-Ro/SSA antibodies, is brought to the emergency department by her husband due to sudden, profound generalized muscle weakness that started this morning. She reports feeling so weak she could not get out of bed. She also complains of new-onset shortness of breath and difficulty taking a deep breath. She currently takes no medications.

Temperature is 37.1°C (98.8°F), blood pressure is 115/75 mm Hg, pulse is 95/min, and respiratory rate is 24/min with shallow breathing. Pulse oximetry is 94% on room air.

Physical examination reveals 2/5 motor strength in the proximal muscles of the upper and lower extremities. Deep tendon reflexes are 1+ bilaterally. Chest auscultation reveals clear lungs bilaterally.

Laboratory studies show:

Serum AnalyteValueReference Range
Sodium (Na+Na^+)140 mEq/L136-145 mEq/L
Potassium (K+K^+)1.8 mEq/L3.5-5.0 mEq/L
Chloride (Cl−Cl^-)118 mEq/L98-106 mEq/L
Bicarbonate (HCO3−HCO_3^-)12 mEq/L22-28 mEq/L
Blood urea nitrogen15 mg/dL8-20 mg/dL
Creatinine0.9 mg/dL0.7-1.3 mg/dL
Urine AnalyteValue
pH6.5
Sodium (Na+Na^+)35 mEq/L
Potassium (K+K^+)20 mEq/L
Chloride (Cl−Cl^-)20 mEq/L

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous administration of potassium chloride

Cevap

Intravenous administration of potassium chloride
The correct answer addresses the most immediate, life-threatening derangement: severe hypokalemia (K+=1.8K^+ = 1.8 mEq/L). This patient's presentation of profound weakness, respiratory distress (due to respiratory muscle paralysis), and a normal anion gap metabolic acidosis with a positive urine anion gap (+35) and a urine pH > 5.5 is the classic presentation of distal (Type 1) renal tubular acidosis (RTA). Type 1 RTA is a well-documented extraglandular complication of Sjögren syndrome, caused by autoimmune-mediated destruction of the α\alpha-intercalated cells in the collecting duct. This prevents H+H^+ secretion, leading to systemic acidosis, and secondarily impairs K+K^+ reabsorption, leading to severe hypokalemia. The most critical step in management is intravenous potassium replacement. Administering alkali (sodium bicarbonate) to correct the acidosis before replacing potassium is strictly contraindicated, as raising the blood pH shifts potassium into the intracellular space, which can precipitate fatal cardiac arrhythmias.

Adım Adım Çözüm

1
Calculate the serum anion gap to classify the metabolic acidosis.
The anion gap is normal (10 mEq/L).
AG=Na+−(Cl−+HCO3−)=140−(118+12)=10AG = Na^+ - (Cl^- + HCO_3^-) = 140 - (118 + 12) = 10. This indicates a normal anion gap metabolic acidosis (NAGMA).
2
Calculate the urine anion gap (UAG) to determine the source of the NAGMA.
The UAG is positive (+35 mEq/L).
UAG=Na++K+−Cl−=35+20−20=+35UAG = Na^+ + K^+ - Cl^- = 35 + 20 - 20 = +35. A positive UAG in NAGMA suggests impaired renal NH4+NH_4^+ excretion, confirming a renal tubular acidosis (RTA).
3
Integrate laboratory findings with the patient's rheumatologic history.
The patient has distal (Type 1) RTA secondary to Sjögren syndrome.
Sjögren syndrome frequently causes autoantibody-mediated damage to the α\alpha-intercalated cells of the distal tubule, leading to failure of H+H^+ secretion (urine pH > 5.5) and severe hypokalemia (1.81.8 mEq/L).
4
Identify the most critical and immediate step in management.
Intravenous potassium chloride must be administered immediately.
The profound weakness and shallow breathing are due to severe hypokalemia. Administering alkali (like bicarbonate) to correct the acidosis before replacing potassium would drive K+K^+ into cells, exacerbating the hypokalemia and risking fatal arrhythmias.

Anahtar Kavram

Extraglandular manifestations of primary Sjögren syndrome include distal (Type 1) renal tubular acidosis, characterized by a normal anion gap metabolic acidosis, a positive urine anion gap, high urine pH, and severe hypokalemia. In the management of Type 1 RTA, potassium must be repleted before initiating alkali therapy.
Tahmini Süre:2m 30s
Soru 2284Soru →

A 24-year-old woman is seen in the ambulatory care center for evaluation of easy bruising and frequent nosebleeds. She reports that her epistaxis occurs spontaneously and often requires up to 20 minutes of direct compression to resolve. Furthermore, she has experienced exceptionally heavy menstrual bleeding since menarche, frequently bleeding through super-absorbent tampons every 2 hours during the heaviest days of her cycle. Last month, a dental extraction was complicated by continuous mucosal oozing that persisted for 48 hours. She has no other medical conditions and does not take any prescription or over-the-counter medications. Her vital signs are within normal limits. Physical examination reveals several small ecchymoses on her bilateral lower extremities, but no petechiae, hemarthroses, or hepatosplenomegaly are noted. The physician suspects an underlying inherited bleeding diathesis.

Arrange the following steps in the diagnostic and management algorithm for this patient in the correct chronological sequence, from initial screening to therapeutic planning.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Initial coagulation screen (CBC, PT, aPTT), 2) Confirmatory factor assays (vWF antigen, ristocetin cofactor activity, factor VIII), 3) Subtype determination (vWF multimer analysis), and 4) Treatment planning (DDAVP trial).
The correct sequence follows the standard diagnostic and management algorithm for von Willebrand disease (vWD). First, an initial hemostatic screen (CBC, PT, aPTT) is required to rule out thrombocytopenia and other broad coagulation defects. Second, once the screen suggests a primary hemostatic defect, specific confirmatory quantitative and qualitative assays (vWF antigen, ristocetin cofactor activity, factor VIII) are performed. Third, after vWD is confirmed, a multimer analysis is conducted to determine the specific subtype (Type 1, 2, or 3), which dictates pathophysiology. Finally, a desmopressin (DDAVP) challenge is administered in a non-bleeding state to assess if the patient has a sufficient release of endogenous vWF and factor VIII, which establishes whether DDAVP can be safely and effectively utilized for future bleeding episodes or surgical prophylaxis.

Adım Adım Çözüm

1
Perform initial hemostatic screening
Identifies a normal platelet count, normal prothrombin time, and potentially mildly prolonged aPTT.
Broadly categorizes the bleeding diathesis and rules out thrombocytopenia or factor deficiencies in the extrinsic/common pathways before pursuing specialized testing.
2
Perform confirmatory von Willebrand disease testing
Demonstrates quantitative or qualitative deficiencies in von Willebrand factor and secondary decreases in factor VIII.
Establishes the definitive diagnosis of von Willebrand disease based on the abnormal screening results and bleeding history.
3
Determine the disease subtype
Characterizes the size distribution of von Willebrand factor multimers.
Differentiates between quantitative defects (Type 1, 3) and qualitative defects (Type 2), which is clinically necessary for guiding specific therapies and avoiding contraindicated treatments.
4
Assess therapeutic responsiveness
Evaluates the patient's rise in von Willebrand factor and factor VIII following the administration of desmopressin (DDAVP).
Determines if DDAVP induces sufficient endogenous factor release to be used for future bleeding episodes or surgical prophylaxis.

Anahtar Kavram

Diagnostic and management sequence for von Willebrand disease
Tahmini Süre:1m 30s
Soru 2285Soru →

A 42-year-old woman is newly diagnosed with seropositive rheumatoid arthritis. She presents with symmetric polyarthritis involving the metacarpophalangeal and proximal interphalangeal joints, morning stiffness lasting 3 hours, and early marginal erosions on hand radiography. Assuming she experiences an initial inadequate clinical response to each successive pharmacological intervention, but eventually achieves and maintains deep remission, arrange the following management steps in the standard evidence-based sequence according to current treatment guidelines.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for rheumatoid arthritis management escalation is: initiation of methotrexate with bridging glucocorticoids, followed by the addition of a biologic DMARD (e.g., TNF inhibitor), then switching to a biologic with an alternative mechanism of action upon failure, and finally tapering the biologic once sustained remission is achieved.
The standard algorithm for managing rheumatoid arthritis follows a stepwise 'treat-to-target' approach. Phase 1 involves starting a conventional synthetic DMARD, universally methotrexate, alongside short-term bridging glucocorticoids to rapidly quell inflammation. If the patient has not reached the target of remission or low disease activity by 3 to 6 months (Phase 2), a biologic DMARD (such as a TNF inhibitor) is added to the background methotrexate. Should this first biologic fail (Phase 3), switching to an agent with an alternative mechanism of action (e.g., tocilizumab or rituximab) is indicated. Finally, once a patient achieves and maintains sustained deep remission for at least 6 months, cautious dose-reduction or interval-spacing of the biologic (Phase 4) is recommended to minimize cumulative toxicity and immunosuppression.

Adım Adım Çözüm

1
Identify the initial treatment for newly diagnosed active rheumatoid arthritis.
Methotrexate plus short-term glucocorticoids is the standard first-line therapy.
This combination provides immediate symptom relief through systemic steroids while allowing time for the disease-modifying effects of methotrexate to take hold.
2
Determine the next step for a patient with an inadequate response to initial methotrexate.
Addition of a biologic DMARD (such as a TNF-alpha inhibitor).
When conventional synthetic DMARDs fail to achieve low disease activity or remission within 3 to 6 months, clinical guidelines recommend combining them with a biologic or targeted synthetic DMARD.
3
Determine the subsequent strategy if the first biologic agent fails.
Switch to a biologic with a different mechanism of action.
If a patient exhibits primary or secondary failure to one class of biologics (e.g., TNF inhibitors), switching to a different class (e.g., IL-6 inhibitors, anti-CD20) offers the best chance of establishing disease control.
4
Identify the management approach once deep, sustained remission is reached.
Cautious tapering (dose reduction or interval spacing) of the biologic agent.
To minimize long-term risks of immunosuppression and medication burden, treatment algorithms mandate attempting to cautiously de-escalate therapy after prolonged clinical remission is maintained.

Anahtar Kavram

The treat-to-target strategy in rheumatoid arthritis involves stepwise escalation from conventional synthetic DMARDs to biologic DMARDs, switching mechanisms upon failure, and eventually attempting cautious de-escalation once sustained remission is achieved.
Tahmini Süre:1m 30s
Soru 2286Soru →

Match each patient's clinical presentation with the most appropriate specific therapeutic intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 42-year-old man on monotherapy for latent tuberculosis is brought in actively seizing. Seizures have persisted for 20 minutes despite adequate doses of intravenous midazolam and phenytoin. Laboratory testing reveals a profound unexplained metabolic acidosis.
A 68-year-old man with opioid use disorder maintained on a synthetic mu-opioid agonist is treated with a macrolide antibiotic for an upper respiratory infection. He presents with recurrent syncope. Telemetry shows bursts of wide-complex tachycardia with constantly changing amplitude around the isoelectric line.
A 55-year-old woman with recurrent depression, stably managed on a long-acting selective serotonin reuptake inhibitor, is hospitalized for a complex soft tissue infection and started on an oxazolidinone antibiotic. Within 48 hours, she develops severe agitation, diaphoresis, a temperature of 39.8°C (103.6°F), and spontaneous myoclonus.
A 34-year-old man managed for acute mania presents with profound confusion, a coarse intentional tremor, and new-onset ataxia after a recent bout of severe rotavirus diarrhea. His estimated glomerular filtration rate has acutely dropped to 25 mL/min/1.73m², and a specific serum drug assay returns at 4.6 mEq/L.
A 75-year-old woman with chronic systolic heart failure and atrial fibrillation presents with anorexia, vomiting, and fatigue. Her spouse notes she recently complained of a yellowish tint to her vision. Cardiac monitoring demonstrates bidirectional ventricular tachycardia, and serum potassium is 5.9 mEq/L.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Latent TB/seizures matches Intravenous pyridoxine. Methadone/macrolide/polymorphic VT matches Intravenous magnesium sulfate. SSRI/linezolid/hyperthermia matches Oral cyproheptadine. Lithium tox/AKI matches Emergent hemodialysis. Heart failure/xanthopsia/bidirectional VT matches Digoxin-specific antibody fragments.
Each correct pairing links a complex toxicological presentation with its specific, life-saving intervention. Isoniazid depletes pyridoxine, leading to refractory seizures. Methadone and macrolides interact to cause QT prolongation and Torsades de pointes, treated with magnesium. Linezolid and SSRIs interact to cause serotonin syndrome, treated with cyproheptadine. Lithium toxicity > 4.0 mEq/L with AKI requires hemodialysis. Digoxin toxicity presenting with severe hyperkalemia and bidirectional VT requires specific antibody fragments.

Adım Adım Çözüm

1
Analyze each patient's clinical presentation and medication history to identify the specific toxidrome or adverse drug reaction.
Patient 1 has isoniazid toxicity. Patient 2 has Torsades de pointes from QT-prolonging agents. Patient 3 has serotonin syndrome. Patient 4 has lithium toxicity. Patient 5 has digoxin toxicity.
Accurate recognition of life-threatening toxidromes based on nuanced historical clues is required before selecting an antidote.
2
Select the definitive, targeted therapy for each identified condition, bypassing generic algorithmic treatments that may be ineffective or harmful.
Pyridoxine for isoniazid seizures; magnesium for Torsades; cyproheptadine for serotonin syndrome; hemodialysis for severe lithium toxicity; and digoxin-specific antibodies for digoxin toxicity with hyperkalemia.
Toxicological emergencies often require specific antidotes or extracorporeal removal rather than standard supportive care.

Anahtar Kavram

Targeted management and antidote selection for complex, multi-drug or severe toxicological emergencies in internal medicine.
Soru 2287Soru →

A 41-year-old woman recently diagnosed with limited cutaneous systemic sclerosis seeks care for progressively worsening color changes and throbbing pain in her fingers upon cold exposure. Over several years, her symptoms progressively escalate despite compliance with each prescribed treatment regimen, eventually leading to severe digital ischemia and impending gangrene. Arrange the following therapies for secondary Raynaud phenomenon in the standard stepwise order of clinical escalation, from initial baseline management to interventions for medically refractory, limb-threatening disease.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence of therapy escalation is: behavioral modifications, followed by oral calcium channel blockers, followed by oral PDE-5 inhibitors, then intravenous prostanoids, and finally digital sympathectomy.
The management of secondary Raynaud phenomenon follows a strict stepwise escalation to balance efficacy with medication side effects and procedural risks. Treatment always begins with nonpharmacologic behavioral modifications. If vasospastic attacks continue, oral vasodilators are introduced, starting with dihydropyridine calcium channel blockers. If symptoms remain refractory, secondary oral agents like PDE-5 inhibitors are added. Progression to severe ischemic complications, such as digital ulcers, mandates escalation to intravenous prostanoids. Finally, if tissue loss is imminent and all medical therapies fail, surgical sympathectomy is performed.

Adım Adım Çözüm

1
Identify the initial baseline management for Raynaud phenomenon.
Behavioral modifications are selected as the first step.
Keeping the core and extremities warm while avoiding triggers like smoking is a mandatory, non-invasive baseline for all patients.
2
Determine the first-line pharmacologic escalation.
Oral dihydropyridine calcium channel blockers are selected as the second step.
When non-pharmacologic measures fail, calcium channel blockers like nifedipine are the safest and most effective initial oral vasodilators.
3
Identify the next step for inadequate response to initial pharmacotherapy.
Addition of a PDE-5 inhibitor is selected as the third step.
Additional oral agents such as sildenafil are added to maximize vasodilation before resorting to invasive or intravenous options.
4
Determine the management for severe complications like digital ulcers.
Intravenous prostanoids are selected as the fourth step.
Active tissue ischemia or ulceration demands potent, systemic therapies like intravenous epoprostenol.
5
Identify the treatment of last resort for limb-threatening disease.
Digital sympathectomy is selected as the final step.
Surgical intervention is highly invasive and is reserved for imminent gangrene when all medical therapies have been exhausted.

Anahtar Kavram

Stepwise escalation of therapy for secondary Raynaud phenomenon in systemic sclerosis.
Soru 2288Soru →

For each patient presentation describing a new diagnosis of primary hypertension with specific comorbidities, select the most appropriate preferred initial antihypertensive medication class.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 62-year-old female with a recent dual-energy x-ray absorptiometry scan indicating significant bone mineral density loss.
A 55-year-old male with chronic kidney disease and a urine albumin-to-creatinine ratio of 400 mg/g.
A 45-year-old female who reports frequent, painful episodes of digital pallor and cyanosis when exposed to cold environments.
A 50-year-old male with a history of an anterior wall myocardial infarction three months ago and a left ventricular ejection fraction of 40%.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Osteoporosis is treated with a Thiazide diuretic; CKD with albuminuria is treated with an ACE inhibitor; Raynaud phenomenon is treated with a Dihydropyridine calcium channel blocker; and prior MI is treated with a Beta-adrenergic antagonist.
Each patient's presentation includes a specific comorbidity that dictates a preferred antihypertensive class based on secondary therapeutic benefits and established mortality reduction guidelines.

Adım Adım Çözüm

1
Identify the primary compelling indication or comorbidity in each patient's presentation.
Patient 1 has osteoporosis. Patient 2 has CKD with overt albuminuria. Patient 3 has Raynaud phenomenon. Patient 4 has a prior myocardial infarction with reduced ejection fraction.
Current hypertension guidelines recommend tailoring initial medical therapy based on specific comorbid conditions to maximize therapeutic benefit.
2
Match each identified comorbidity to the antihypertensive class that provides the most advantageous secondary benefit or mortality reduction.
Osteoporosis benefits from thiazides due to calcium retention. CKD with albuminuria requires ACE inhibitors for renoprotection. Raynaud phenomenon improves with the vasodilatory effects of dihydropyridines. A prior MI requires beta-blockers to reduce cardiac workload and improve survival.
Selecting the optimal pharmacological agent requires synthesizing the diagnosis with the pleiotropic effects of the medication.

Anahtar Kavram

Tailoring initial antihypertensive therapy based on compelling clinical indications and patient-specific comorbidities.
Soru 2289Soru →

During a scheduled wellness examination, a 72-year-old male mentions to his physician that his daily neighborhood walks have become increasingly difficult over the last three months due to profound fatigue. He has no prior history of cardiopulmonary disease and denies melena, hematochezia, changes in bowel habits, or abdominal pain. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 135/82 mm Hg, pulse 86/min, and respirations 14/min. Physical examination demonstrates noticeable conjunctival pallor. The abdomen is soft and non-tender without hepatosplenomegaly.

Laboratory evaluation reveals the following:

TestResultReference Range
Hemoglobin9.1 g/dL13.5-17.5 g/dL
Mean corpuscular volume (MCV)73 fL80-100 fL
Leukocyte count6,500/mm3^34,500-11,000/mm3^3
Platelet count410,000/mm3^3150,000-400,000/mm3^3
Serum iron25 μ\mug/dL65-175 μ\mug/dL
Total iron-binding capacity (TIBC)460 μ\mug/dL250-400 μ\mug/dL
Serum ferritin9 ng/mL20-250 ng/mL

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Referral for colonoscopy and esophagogastroduodenoscopy

Cevap

Referral for colonoscopy and esophagogastroduodenoscopy is the correct next step to evaluate for gastrointestinal malignancy.
The correct answer is referral for colonoscopy and esophagogastroduodenoscopy. This patient presents with laboratory findings pathognomonic for iron deficiency anemia (microcytosis, low serum iron, high total iron-binding capacity, and low ferritin). In adult men and postmenopausal women, the most common and critical cause of iron deficiency is occult gastrointestinal blood loss. Because gastrointestinal malignancies (such as colorectal carcinoma) can present solely with iron deficiency anemia prior to the onset of bowel symptoms or overt bleeding, bidirectional endoscopy is mandatory to rule out cancer.

Adım Adım Çözüm

1
Analyze the complete blood count and iron studies.
The patient has a microcytic anemia (MCV 73 fL) with low serum iron, high TIBC, and low ferritin (9 ng/mL).
To establish the specific etiology of the patient's anemia, which clearly indicates iron deficiency.
2
Determine the clinical significance of iron deficiency in this specific demographic.
In an elderly male, iron deficiency anemia is highly suspicious for chronic gastrointestinal blood loss.
To recognize that unlike in menstruating women, iron deficiency in older adults is rarely due to physiologic blood loss or pure dietary deficiency.
3
Select the appropriate diagnostic intervention.
Bidirectional gastrointestinal endoscopy (colonoscopy and esophagogastroduodenoscopy) is indicated.
To rule out occult gastrointestinal malignancies, such as colon cancer, which are the most critical, life-threatening causes of occult blood loss in this age group.

Anahtar Kavram

In adult males and postmenopausal females, new-onset iron deficiency anemia must be presumed to be caused by gastrointestinal bleeding (often occult malignancy) until proven otherwise, necessitating endoscopic evaluation.
Tahmini Süre:1m 0s
Soru 2290Soru →

A 6868-year-old man is admitted to the general medical floor with a 44-day history of fever, chills, and a cough productive of rust-colored sputum. His past medical history is significant only for benign prostatic hyperplasia. He has not had any recent hospitalizations, does not reside in a nursing facility, and has not received any antibiotics in the past year. Vital signs on presentation include a temperature of 38.8∘C38.8^{\circ}\text{C} (101.8∘F101.8^{\circ}\text{F}), blood pressure of 115/76 mm Hg115/76\text{ mm Hg}, pulse of 102/min102/\text{min}, and respiratory rate of 24/min24/\text{min}. Oxygen saturation is 94%94\% on 2 L/min2\text{ L/min} via nasal cannula. Chest radiography demonstrates a dense consolidation in the left lower lobe. The admitting physician empirically prescribes intravenous piperacillin-tazobactam and vancomycin. A high-quality sputum Gram stain demonstrates many polymorphonuclear leukocytes and abundant Gram-positive diplococci. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Cevabı ve açıklamayı göster

Cevap: Switch to intravenous ceftriaxone and oral azithromycin

Cevap

Switch to intravenous ceftriaxone and oral azithromycin
This patient presents with a classic clinical picture of community-acquired pneumonia (CAP), highly likely due to Streptococcus pneumoniae given the rust-colored sputum and characteristic Gram-positive diplococci on Gram stain. Because he has no recent healthcare exposure, prior antibiotic use, or structural lung disease, he lacks risk factors for multidrug-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. Therefore, the empiric use of piperacillin-tazobactam and vancomycin in the emergency department was inappropriately broad. Principles of antibiotic stewardship dictate that therapy should be promptly de-escalated. The standard empiric treatment for a patient admitted to the medical ward for CAP is a beta-lactam (e.g., ceftriaxone, cefotaxime) combined with a macrolide (e.g., azithromycin) to cover both typical and atypical pathogens. Transitioning to this regimen provides optimal coverage while minimizing the risk of adverse drug events and antimicrobial resistance.

Adım Adım Çözüm

1
Identify the primary clinical syndrome.
The patient's acute fever, productive cough, focal consolidation on radiography, and Gram-positive diplococci on sputum stain point to typical community-acquired pneumonia (CAP), most likely caused by Streptococcus pneumoniae.
Establishing the correct diagnosis guides the selection of empiric pharmacotherapy.
2
Assess the patient for risk factors for multidrug-resistant (MDR) organisms.
The patient resides in the community, has not been hospitalized recently, and has not received prior antibiotics, meaning he is at very low risk for Pseudomonas aeruginosa or methicillin-resistant Staphylococcus aureus (MRSA).
Risk stratification determines whether broad-spectrum antibiotics are warranted.
3
Evaluate the current therapeutic regimen against principles of antibiotic stewardship.
Piperacillin-tazobactam and vancomycin provide excessively broad coverage that is unwarranted for this patient, exposing him to unnecessary risks of toxicity and resistance.
Initial empiric regimens often need to be de-escalated once a patient's risk profile and preliminary data (like Gram stains) are reviewed.
4
Select the optimal standard regimen for inpatient CAP.
A beta-lactam (like ceftriaxone) combined with a macrolide (like azithromycin) provides appropriate coverage for typical pathogens (e.g., S. pneumoniae) and atypical pathogens (e.g., Mycoplasma, Legionella).
This combination represents standard-of-care empiric therapy for non-severe inpatient CAP without MDR risk factors.

Anahtar Kavram

Antibiotic stewardship in community-acquired pneumonia requires avoiding broad-spectrum agents targeting MRSA and Pseudomonas aeruginosa unless specific epidemiological risk factors are present, and instead utilizing targeted regimens like a beta-lactam plus a macrolide.
Soru 2291Soru →

An athletic 24-year-old male construction worker presents with an 8-month history of insidious-onset lower back pain and severe morning stiffness. He reports that the stiffness often lasts for over an hour after awakening but gradually improves as he engages in physical labor throughout the day. His symptoms frequently awaken him in the second half of the night. He denies any radiating leg pain, numbness, or bowel/bladder dysfunction. Physical examination reveals a restricted range of motion in the lumbar spine, as evidenced by a modified Schober test expansion of only 3 cm3\text{ cm} (normal >5 cm>5\text{ cm}). Neurologic examination of the lower extremities is unremarkable.

Assuming the patient's initial imaging studies do not yield a definitive diagnosis and his symptoms remain unacceptably high despite initial interventions, arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for establishing the diagnosis and managing this patient according to standard rheumatologic guidelines.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Plain radiography -> MRI of sacroiliac joints -> Continuous NSAID therapy -> Assessment after 2-4 weeks -> TNF-alpha inhibitor therapy.
The patient presents with classic features of inflammatory back pain (insidious onset, morning stiffness lasting >1 hour>1\text{ hour}, improvement with exercise, nighttime awakening), highly suspicious for axial spondyloarthritis (axSpA). The standard chronological approach begins with plain radiography of the sacroiliac joints to look for definitive structural damage. Because early disease often lacks radiographic changes, an MRI of the sacroiliac joints is the required next step if X-rays are negative or equivocal, as it can detect active osteitis. Once the diagnosis is established, the first-line pharmacologic intervention is a continuous, scheduled trial of NSAIDs. If the patient has persistently high disease activity upon reassessment after at least 22 to 44 weeks of continuous NSAID therapy, escalation to a biologic agent, such as a TNF-alpha inhibitor, is indicated.

Adım Adım Çözüm

1
Select plain radiography of the sacroiliac joints as the initial step.
Initial assessment for structural damage is performed.
Guidelines require plain X-rays first due to wide availability and the ability to immediately establish a diagnosis of radiographic axial spondyloarthritis if classic changes are present.
2
Select MRI of the sacroiliac joints as the second step.
Detection of active osteitis/bone marrow edema.
In early disease, X-rays are often negative. MRI is required to diagnose non-radiographic axial spondyloarthritis when X-rays are non-diagnostic but clinical suspicion remains high.
3
Select the initiation of a continuous, scheduled NSAID course as the third step.
First-line pharmacotherapy is established.
Once diagnosis is confirmed, NSAIDs given at full anti-inflammatory doses on a continuous schedule (rather than PRN) are the primary treatment for axial spondyloarthritis.
4
Select the reassessment of disease activity after 2 to 4 weeks as the fourth step.
Verification of treatment failure or success.
A documented failure of a continuous NSAID trial is a strict prerequisite before escalating to more aggressive, expensive immunosuppressive therapies.
5
Select the initiation of a TNF-alpha inhibitor as the final step.
Escalation to second-line biologic therapy.
Biologic agents (like TNF or IL-17 inhibitors) are strictly reserved for patients with active disease who have failed to respond adequately to continuous NSAIDs.

Anahtar Kavram

The diagnostic and therapeutic escalation pathway for axial spondyloarthritis requires a stepwise approach: initial plain films followed by MRI if negative, then continuous NSAIDs as first-line therapy, culminating in biologic agents only if NSAIDs fail after a defined trial period.
Soru 2292Soru →

Match the following key socioemotional and play milestones to the most typical chronological age at which they first emerge during normal pediatric development.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

2 months
6 months
9 months
24 months (2 years)
48 months (4 years)

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matching correctly aligns normal socioemotional development: 2 months with the social smile, 6 months with stranger anxiety, 9 months with separation anxiety, 24 months with parallel play, and 48 months with cooperative play.
Each socioemotional milestone aligns with highly standardized pediatric developmental timelines. Two-month-olds begin to smile socially. Six-month-olds recognize their primary caregivers and exhibit fear of strangers. Nine-month-olds understand that caregivers still exist even when out of sight, causing separation anxiety. Two-year-olds play alongside peers independently (parallel play), and four-year-olds play together with shared goals (cooperative play).

Adım Adım Çözüm

1
Identify the earliest social milestone, the social smile.
The social smile reliably appears at 2 months of age.
This is the first major reciprocal socioemotional milestone assessed in well-child visits.
2
Differentiate between the onset of stranger anxiety and separation anxiety.
Stranger anxiety typically emerges around 6 months, followed by separation anxiety at 9 months.
Stranger anxiety relies on recognizing familiar versus unfamiliar faces. Separation anxiety requires the subsequent development of object permanence.
3
Distinguish between types of play based on the child's age in years.
Parallel play matches 24 months (2 years), while cooperative play matches 48 months (4 years).
Toddlers lack the theory of mind required for shared goals (parallel play), whereas preschool-aged children develop the capacity to negotiate rules and share tasks (cooperative play).

Anahtar Kavram

Normal socioemotional and play development in pediatrics follows a predictable chronological sequence, progressing from basic interpersonal responses to complex peer interactions.
Soru 2293Soru →

A 27-year-old woman is brought to the emergency department due to a 2-day history of progressively worsening shortness of breath, fever, and coughing up blood-tinged sputum. She has a history of systemic lupus erythematosus (SLE) complicated by class IV lupus nephritis, for which she takes mycophenolate mofetil and low-dose prednisone. Her temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 105/65 mmHg105/65\text{ mmHg}, pulse is 124/min124/\text{min}, and respirations are 28/min28/\text{min}. Oxygen saturation is 86%86\% on room air. Physical examination reveals a pale, fatigued woman in moderate respiratory distress. Auscultation of the lungs reveals diffuse bilateral crackles. There is no jugular venous distension. Cardiac examination shows a regular tachycardia with no murmurs, rubs, or gallops. Trace bilateral pedal edema is present.

Laboratory results:
Laboratory TestResultReference Range
Hemoglobin7.2 g/dL7.2\text{ g/dL} (Baseline: 11.5 g/dL11.5\text{ g/dL})12.0−16.0 g/dL12.0 - 16.0\text{ g/dL}
Leukocyte count5,400/mm35,400/\text{mm}^34,500−11,000/mm34,500 - 11,000/\text{mm}^3
Platelet count140,000/mm3140,000/\text{mm}^3150,000−400,000/mm3150,000 - 400,000/\text{mm}^3
Blood urea nitrogen48 mg/dL48\text{ mg/dL}7−18 mg/dL7 - 18\text{ mg/dL}
Serum creatinine2.3 mg/dL2.3\text{ mg/dL} (Baseline: 1.4 mg/dL1.4\text{ mg/dL})0.6−1.2 mg/dL0.6 - 1.2\text{ mg/dL}
Arterial blood gas (room air):
ParameterResult
pH7.507.50
pCO2_226 mmHg26\text{ mmHg}
pO2_254 mmHg54\text{ mmHg}
HCO3−_3^-20 mEq/L20\text{ mEq/L}

Chest radiograph reveals new diffuse, bilateral patchy alveolar infiltrates. An emergency bedside echocardiogram demonstrates a left ventricular ejection fraction of 60%60\% with normal right ventricular function and no significant valvular abnormalities.

Which of the following diagnostic findings would most likely be seen on further evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Progressively bloodier return on sequential aliquots of bronchoalveolar lavage fluid

Cevap

Progressively bloodier return on sequential aliquots of bronchoalveolar lavage fluid
Diffuse alveolar hemorrhage (DAH) is a rare but life-threatening complication of systemic lupus erythematosus (SLE), particularly in patients with active lupus nephritis. The classic presentation includes dyspnea, fever, hemoptysis, and new bilateral alveolar infiltrates. The critical distinguishing feature in this vignette is the acute, profound drop in hemoglobin (from 11.5 to 7.2 g/dL), which indicates massive blood loss. Given the absence of gastrointestinal or other external bleeding, this internal blood loss must be localized to the pulmonary parenchyma. The gold standard for diagnosing DAH is bronchoscopy with bronchoalveolar lavage (BAL). In DAH, sequential aliquots of BAL fluid become progressively bloodier, confirming active alveolar bleeding rather than localized airway trauma from the procedure. Prompt recognition is critical as treatment requires high-dose corticosteroids and immunosuppressive therapy.

Adım Adım Çözüm

1
Analyze the patient's vital signs and physical examination.
The patient is hypoxic, tachypneic, and tachycardic with bilateral lung crackles, indicating an acute pulmonary process.
To establish the primary organ system involved in the acute decompensation.
2
Evaluate the laboratory data and imaging.
Chest radiograph shows diffuse bilateral infiltrates. Labs reveal an acute drop in hemoglobin by 4.3 g/dL without signs of external bleeding. Echocardiogram is normal.
To differentiate between infectious, cardiogenic, and hemorrhagic causes of pulmonary infiltrates.
3
Synthesize the findings with the patient's medical history.
A patient with active SLE (lupus nephritis) presenting with new pulmonary infiltrates, hemoptysis, and massive unexplained anemia is highly suspicious for diffuse alveolar hemorrhage (DAH).
To formulate the most likely diagnosis based on the clinical triad.
4
Identify the diagnostic gold standard for the suspected condition.
Bronchoscopy with bronchoalveolar lavage (BAL) showing progressively bloody aliquots confirms DAH.
To answer the specific question asked in the stem regarding further evaluation findings.

Anahtar Kavram

Diffuse alveolar hemorrhage in systemic lupus erythematosus is characterized by the triad of hemoptysis, diffuse pulmonary infiltrates, and an acute drop in hemoglobin. Bronchoscopy with serial bronchoalveolar lavage confirms the diagnosis.
Soru 2294Soru →

Match each patient's clinical presentation with the most appropriate initial pharmacological intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old man with a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of 22% and an LDL cholesterol of 145 mg/dL
A 50-year-old woman with newly diagnosed type 2 diabetes mellitus, a hemoglobin A1c of 7.8%, and normal renal function
A 60-year-old man with newly diagnosed primary hypertension and osteoporosis, with no history of diabetes or heart failure
A 55-year-old woman with chronic kidney disease, severe albuminuria, and newly diagnosed primary hypertension

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches pair each specific clinical presentation with its guideline-directed first-line pharmacological therapy.
Each correct pairing reflects the standard of care for initial pharmacological management in primary care: statins for high ASCVD risk, biguanides for uncomplicated type 2 diabetes, thiazides for hypertension with osteoporosis, and ACE inhibitors for hypertension with proteinuric CKD.

Adım Adım Çözüm

1
Analyze the lipid profile and ASCVD risk.
Identify the indication for a high-intensity statin.
Current guidelines recommend high-intensity statin therapy for primary prevention in patients with a 10-year ASCVD risk of 20% or higher.
2
Analyze the new diabetes diagnosis.
Identify the indication for metformin.
A biguanide is the established first-line agent for newly diagnosed type 2 diabetes mellitus.
3
Analyze the hypertension case with comorbid osteoporosis.
Identify the indication for a thiazide diuretic.
Thiazides promote renal calcium reabsorption, improving bone mineral density while effectively lowering blood pressure.
4
Analyze the hypertension case with comorbid CKD and albuminuria.
Identify the indication for an ACE inhibitor.
ACE inhibitors reduce intraglomerular pressure, specifically slowing the progression of proteinuric kidney disease.

Anahtar Kavram

First-line pharmacological management of common outpatient chronic diseases
Soru 2295Soru →

A 30-month-old boy is brought to the office by his parents for a routine well-child visit. His parents express concern regarding his development. They note that he does not play cooperatively with other children at the local park, preferring to play independently next to them, and he frequently refuses to share his toys. Additionally, they are worried because he cannot yet pedal a tricycle or draw a circle. On physical examination, the child is active and cooperative. He walks up the examination step stool by placing both feet on each step and successfully jumps in place. He builds a tower of eight blocks and holds a crayon to make vertical lines. He speaks in two- to three-word phrases, has a vocabulary of approximately 100 words, and refers to himself as "I." His speech is understood by the physician roughly half the time. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Reassure the parents that his development is age-appropriate

Cevap

Reassure the parents that his development is age-appropriate.
The correct action is to provide reassurance. The patient is exhibiting entirely normal milestones for a 30-month-old (2.5 years). He demonstrates appropriate gross motor skills (jumping in place, walking up stairs placing both feet on a step), fine motor skills (tower of 8 blocks, vertical line), language skills (100 words, 2-word phrases, 50% intelligible), and social skills (parallel play). The parents' concerns refer to milestones that are not expected until age 3 (riding a tricycle, copying a circle) or age 4 (cooperative play).

Adım Adım Çözüm

1
Evaluate the parents' specific developmental concerns against established pediatric milestones.
Pedaling a tricycle (gross motor) and drawing a circle (fine motor) are expected at 3 years (36 months). Cooperative play and sharing (social) emerge near 4 years.
Parents frequently misinterpret advanced milestones as delays if they are unaware of the normal developmental timeline.
2
Assess the patient's currently demonstrated skills.
The patient jumps in place (gross motor, 30 mo), builds an 8-block tower (fine motor, 30 mo), speaks in 2-3 word phrases with 50% intelligibility (language, 24-30 mo), and engages in parallel play (social, 24-36 mo).
Establishing the child's actual developmental age across all four domains (gross motor, fine motor, language, social) is necessary to rule out isolated or global delays.
3
Determine the appropriate clinical intervention based on the findings.
Because all evaluated domains map perfectly to a 30-month-old developmental stage, no formal referrals or targeted screenings are indicated.
When a child's development is normal, the standard of care is reassurance and anticipatory guidance.

Anahtar Kavram

Normal pediatric developmental milestones at 2.5 to 3 years of age, distinguishing between expected toddler behaviors and actual developmental delays.
Soru 2296Soru →

Parents bring their 2-year-old son to the pediatric clinic because they are highly concerned about his frequent, severe temper tantrums. When he is denied a toy, he frequently throws himself on the floor, kicks, and screams. During the most severe episodes, he cries vigorously, stops breathing, and turns slightly blue around the lips before taking a deep breath and recovering spontaneously. He has never lost consciousness.

On developmental assessment, the boy walks well, runs, kicks a ball, and can build a tower of 6 cubes. He points to objects he wants and brings books to his parents to read. His vocabulary consists of "mama," "dada," "dog," and "no." He does not put two words together. He makes good eye contact, smiles reciprocally, and plays alongside his older sister in the waiting room.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Formal audiometric testing

Cevap

The correct answer is formal audiometric testing.
The correct action is to order a formal hearing assessment. This patient exhibits normal gross motor, fine motor, and social development for a 24-month-old. His tantrums and cyanotic breath-holding spells, which occur in the setting of frustration and are followed by rapid spontaneous recovery, are benign and represent a normal phase of toddler behavioral development. However, his expressive language is significantly delayed. At 24 months of age, a typically developing toddler should have an expressive vocabulary of at least 50 words and should be forming 2-word phrases (e.g., "want milk," "go bye-bye"). Because isolated speech and language delay can be the first and only sign of hearing impairment (often acquired through silent otitis media with effusion), formal audiometry is universally indicated as the first step in evaluation before initiating speech therapy or pursuing more extensive neurodevelopmental testing.

Adım Adım Çözüm

1
Evaluate the chief complaint (temper tantrums and breath-holding spells).
Identify these behaviors as normal variations of toddler autonomy (benign cyanotic breath-holding spells) requiring no medical intervention.
Differentiating pathological neurological events from benign developmental behaviors prevents unnecessary testing.
2
Analyze the developmental milestones across all domains for a 24-month-old (2 years).
Gross motor (runs, kicks ball), fine motor (6-cube tower), and social (parallel play, eye contact) domains are completely normal. Language domain is delayed (only 4 words, no 2-word phrases).
Normal language development at 24 months requires a vocabulary of 50 to 200 words and the ability to combine 2 words into short phrases.
3
Determine the first step in the workup of an isolated speech/language delay.
Select formal hearing assessment (audiometry).
Undiagnosed hearing loss (e.g., from recurrent otitis media) is a leading cause of speech delay. Hearing must be formally evaluated before initiating speech therapy or other neurodevelopmental testing.

Anahtar Kavram

Any pediatric patient presenting with a speech or language delay must undergo a formal hearing assessment as the first diagnostic step, even if the newborn hearing screen was normal.
Soru 2297Soru →

A 5-year-old boy is brought to the clinic for a well-child examination prior to starting kindergarten. His medical history is notable for severe polyarticular juvenile idiopathic arthritis. For the past 6 months, his condition has been exceptionally well controlled on a regimen of subcutaneous etanercept and oral methotrexate. His mother states he has been entirely asymptomatic. A review of his immunization records shows that he received all required infant and toddler vaccinations up to age 2, but he has not yet received any of his standard preschool booster vaccines. The mother also expresses concern that her son cannot yet copy a diamond or independently tie his shoelaces. Observation in the clinic reveals he can skip, copy a triangle, and accurately count to 10. Vital signs and physical examination are normal. Which of the following is the most appropriate management plan for this patient today?

Cevabı ve açıklamayı göster

Cevap: Administer DTaP and IPV; reassure the mother regarding his development

Cevap

Administer DTaP and IPV; reassure the mother regarding his development
The correct management plan involves administering the inactivated vaccines (DTaP and IPV) while deferring the live-attenuated vaccines (MMR and varicella). This 5-year-old patient is severely immunocompromised due to his treatment with etanercept (a biologic agent) and methotrexate. Live-attenuated vaccines pose a risk of uncontrolled replication and disseminated disease in such patients and are therefore strictly contraindicated. Conversely, inactivated vaccines are safe and should be given on schedule to provide protection, even though the total immune response may be blunted. Regarding development, his ability to skip, copy a triangle, and count to 10 confirms normal 5-year-old milestones. His inability to copy a diamond or tie his shoelaces is appropriate for his age, as these are typically mastered at age 6; therefore, reassurance is the correct action.

Adım Adım Çözüm

1
Determine the required vaccines for a 5-year-old child.
The standard preschool boosters given between 4 and 6 years of age are DTaP, IPV, MMR, and varicella.
Identifying the baseline requirement is necessary before adjusting for the patient's specific medical conditions.
2
Evaluate the patient's immune status based on current medications.
The patient is taking etanercept (a TNF-alpha inhibitor) and methotrexate, which cause significant immunosuppression.
Immunosuppression status dictates the safety profile of different vaccine types.
3
Apply vaccine contraindication guidelines for immunocompromised patients.
Live-attenuated vaccines (MMR, varicella) are strictly contraindicated, but inactivated vaccines (DTaP, IPV) are safe and should be administered.
Live vaccines can cause disseminated, life-threatening infections in immunosuppressed hosts, whereas inactivated vaccines pose no such risk.
4
Assess the patient's developmental milestones against age expectations.
Skipping, copying a triangle, and counting to 10 are normal 5-year-old milestones. Tying shoelaces and copying a diamond are typical 6-year-old milestones.
Determining if the mother's concern is valid dictates whether reassurance or a specialist referral is appropriate.

Anahtar Kavram

Live-attenuated vaccines are contraindicated in severely immunocompromised patients, whereas inactivated vaccines remain indicated. Additionally, tying shoelaces and copying a diamond are typical 6-year-old milestones, not 5-year-old milestones.
Tahmini Süre:1m 30s
Soru 2298Soru →

A 54-year-old man is brought to the emergency department by his partner due to a 24-hour history of severe headache, high fever, and worsening confusion. He has a history of advanced HIV infection and has been non-adherent to his antiretroviral therapy. His temperature is 39.4°C (102.9°F), blood pressure is 105/65 mmHg, and heart rate is 118/min. He is lethargic and oriented only to person. Physical examination is notable for marked resistance to passive neck flexion. Fundoscopic evaluation reveals blurring of the optic disc margins bilaterally. Arrange the following diagnostic and therapeutic interventions in the most appropriate chronological order for the immediate management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of interventions is: 1) Draw peripheral blood cultures, 2) Administer empiric intravenous antibiotics and dexamethasone, 3) Obtain a non-contrast CT scan of the head, and 4) Perform a lumbar puncture.
The standard sequence for managing suspected bacterial meningitis with indications for a CT head prior to a lumbar puncture is: Blood cultures -> Empiric antibiotics -> CT head -> Lumbar puncture. Blood cultures are drawn first so they are not sterilized by antibiotics. Antibiotics are given immediately next because treatment delays are fatal. CT head is done next to rule out a space-occupying lesion due to the patient's 'red flag' symptoms (HIV, confusion, papilledema). Finally, a lumbar puncture is safely performed once mass effect is ruled out.

Adım Adım Çözüm

1
Draw peripheral blood cultures
Blood samples are secured for microbial growth before sterilization occurs.
Administering antibiotics prior to drawing blood cultures can sterilize the blood and prevent the identification of the causative organism.
2
Administer empiric intravenous antibiotics and dexamethasone
Broad-spectrum coverage and anti-inflammatory therapy are initiated.
Bacterial meningitis is a rapidly progressive and highly fatal disease; empiric therapy must be started immediately and never delayed for imaging or lumbar puncture.
3
Obtain a non-contrast CT scan of the head
Cranial imaging rules out mass effect, midline shift, or a space-occupying lesion.
The patient has papilledema, altered mental status, and is severely immunocompromised, placing him at high risk for intracranial pathology (e.g., toxoplasmosis, primary CNS lymphoma) that could cause herniation if a lumbar puncture is performed blindly.
4
Perform a lumbar puncture for cerebrospinal fluid analysis
Cerebrospinal fluid is obtained for Gram stain, culture, and specific antigen testing.
Once mass effect is ruled out by the CT scan, it is safe to proceed with the definitive diagnostic test to tailor long-term antimicrobial therapy.

Anahtar Kavram

The chronological management of suspected bacterial meningitis in patients requiring neuroimaging prior to lumbar puncture.
Soru 2299Soru →

For each of the following classic clinical presentations of infectious diseases, select the most appropriate first-line targeted antimicrobial therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 20-year-old male notes a single, indurated, painless ulcer on his glans penis. He has bilateral rubbery inguinal lymph nodes. Point-of-care darkfield microscopy shows spirochetes.
A 22-year-old female college student complains of painful urination and increased urinary frequency for two days. She is afebrile and has no costovertebral angle tenderness.
A 54-year-old male develops a 10-cm annular rash with central clearing on his lower extremity two weeks after a camping trip in Connecticut.
A 32-year-old female presents with a profuse, malodorous, yellow-green vaginal discharge and vulvar irritation. Wet mount microscopy reveals motile, flagellated protozoa.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Primary syphilis matches with intramuscular benzathine penicillin G. Uncomplicated acute cystitis matches with oral nitrofurantoin. Early localized Lyme disease matches with oral doxycycline. Trichomoniasis matches with oral metronidazole.
Each specific clinical scenario presents classic pathognomonic signs of an infectious disease that corresponds directly to a well-established, first-line antimicrobial therapy per current medical guidelines.

Adım Adım Çözüm

1
Analyze the first clinical vignette to identify the underlying pathogen or disease state.
The painless chancre and spirochetes indicate primary syphilis.
Accurate diagnosis is required to select the correct targeted antimicrobial.
2
Identify the standard first-line therapy for the diagnosed condition.
Primary syphilis is treated with intramuscular benzathine penicillin G.
Treatment guidelines dictate specific regimens to ensure efficacy and prevent complications.
3
Repeat the diagnostic and therapeutic pairing process for the remaining vignettes.
Cystitis pairs with nitrofurantoin; Lyme disease pairs with doxycycline; Trichomoniasis pairs with metronidazole.
Each distinct presentation requires a specific targeted agent.

Anahtar Kavram

First-line empiric and targeted antimicrobial therapies for classic infectious disease presentations.
Tahmini Süre:1m 30s
Soru 2300Soru →

Match each clinical presentation of infective endocarditis or severe bacteremia to its most appropriate targeted antimicrobial regimen.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Prosthetic aortic valve (placed 3 months ago) endocarditis growing methicillin-resistant Staphylococcus epidermidis (MRSE)
Native mitral valve endocarditis growing Enterococcus faecalis in a patient with stage 3 chronic kidney disease
Native tricuspid valve endocarditis growing methicillin-susceptible Staphylococcus aureus (MSSA) currently on empiric vancomycin
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with a rapidly rising serum creatinine on day 4 of vancomycin therapy

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Prosthetic valve MRSE matches with Vancomycin/Rifampin/Gentamicin. E. faecalis with CKD matches with Ampicillin/Ceftriaxone. MSSA matches with Cefazolin. MRSA with nephrotoxicity matches with Daptomycin.
Each correct pairing aligns with infectious disease guidelines: staphylococcal prosthetic valves require rifampin and gentamicin adjuncts; MSSA strictly requires beta-lactam de-escalation; enterococcal endocarditis with renal impairment requires aminoglycoside-sparing dual beta-lactams; and vancomycin-induced nephrotoxicity necessitates a switch to daptomycin.

Adım Adım Çözüm

1
Analyze the prosthetic valve endocarditis case (MRSE).
Identify the need for biofilm penetration.
Staphylococcal infections of prosthetic material develop robust biofilms. Rifampin is required to penetrate the biofilm, but it cannot be used alone due to rapid resistance. It must be combined with vancomycin (for MRSE) and gentamicin (for early synergy).
2
Analyze the E. faecalis endocarditis case with chronic kidney disease.
Select a synergistic regimen that spares the kidneys.
Enterococcal endocarditis requires synergy. While ampicillin plus gentamicin is traditional, ampicillin plus ceftriaxone achieves synergy through dual penicillin-binding protein inhibition and completely avoids nephrotoxic aminoglycosides.
3
Evaluate the MSSA endocarditis case on empiric vancomycin.
Determine the optimal definitive therapy.
Vancomycin is inferior to anti-staphylococcal penicillins (nafcillin) or first-generation cephalosporins (cefazolin) for MSSA. Standard antimicrobial stewardship dictates de-escalation to cefazolin.
4
Assess the MRSA bacteremia case complicated by acute kidney injury.
Choose a bactericidal agent active against MRSA with a different toxicity profile.
Vancomycin is notoriously nephrotoxic. Daptomycin is highly bactericidal against MRSA and is not nephrotoxic, making it the ideal switch when acute kidney injury occurs.

Anahtar Kavram

Targeted antimicrobial therapy for bacteremia and endocarditis requires adjustment based on pathogen susceptibility (e.g., MRSA vs. MSSA), infection site (prosthetic biofilm vs. native valve), and patient-specific toxicities (nephrotoxicity).
ÖncekiSayfa 115 / 414Sonraki